Integrative Multi‐Omics and Experimental Validation Define RELB as an Immune‐Related Prognostic Driver in Ovarian Cancer
ABSTRACT Ovarian cancer (OC) is one of the most aggressive gynecological malignancies worldwide. The tumor microenvironment and transcriptomic alterations play important roles in OC progression and therapeutic response. Integrative bulk and single‐cell transcriptomic analyses may facilitate the identification of progno...